About Genomic health
Genomic Health: Revolutionizing Cancer Care with Precision Medicine
Cancer is one of the most dreaded diseases in the world, affecting millions of people every year. It is a complex disease that requires personalized treatment based on the patient's unique genetic makeup. Genomic Health, a leading precision medicine company, is at the forefront of cancer care innovation, providing patients and healthcare providers with cutting-edge genomic testing solutions.
Founded in 2000 by Randy Scott and Patrick Terry, Genomic Health has been dedicated to transforming cancer care through advanced genomic testing. The company's mission is to improve patient outcomes by providing accurate and actionable information that helps physicians make informed treatment decisions.
Genomic Health offers a range of diagnostic tests that analyze the genetic makeup of tumors to determine their aggressiveness and potential response to specific treatments. These tests are designed to provide personalized treatment recommendations based on each patient's unique genetic profile.
One of Genomic Health's flagship products is Oncotype DX®, a genomic test that analyzes the activity levels of 21 genes within a tumor sample to predict its likelihood of recurrence and response to chemotherapy. This test has been extensively validated in clinical trials and has become an essential tool for breast cancer patients worldwide.
In addition to breast cancer, Genomic Health also offers diagnostic tests for prostate cancer (Oncotype DX Prostate), colon cancer (ColoPrint), and melanoma (DecisionDx-Melanoma). These tests provide valuable insights into each patient's tumor biology, enabling physicians to tailor their treatment plans accordingly.
Genomic health has also developed innovative liquid biopsy technology called Signatera™ which can detect circulating tumor DNA from blood samples with high sensitivity & specificity across multiple cancers including lung & colorectal cancers as well as bladder & breast cancers among others.
The company's commitment towards precision medicine extends beyond diagnostics; it also provides comprehensive support services for patients undergoing treatment. From financial assistance programs to educational resources on managing side effects, Genomic Health ensures that patients receive holistic care throughout their journey.
With over two decades of experience in precision medicine research & development , Genomics health continues its efforts towards advancing oncology research through collaborations with academic institutions such as MD Anderson Cancer Center , Memorial Sloan Kettering Cancer Center etc.,
In conclusion, Genomics health has revolutionized cancer care by leveraging cutting-edge genomics technology for personalized diagnosis and treatment planning. Its commitment towards improving patient outcomes through precision medicine makes it one-of-a-kind in this field . With its innovative approach towards oncology research , we can expect more breakthroughs from this pioneering company in years ahead .